Platform Transfer Partnerships

Adimab transfers our proprietary yeast-based discovery platform directly to your labs. With training at Adimab and onsite, your team is enabled to discover and engineer IgGs and generate multispecifics without limitations on target or therapeutic area.

Independent discovery, unlimited scope

Our platform transfer equips your team with a set of unique library diversities that can be used to pursue any target. These diversities and the platform know-how have been used by our transfer partners on more than 200 internal programs. Even after training and enablement, Adimab continues to support partners in their discovery and engineering efforts to maximize their success with the platform.
Scientist operating a high-throughput automated system in a laboratory setting.

Training, support, and peer community

Adimab provides ongoing support and regular platform updates to keep your system at the leading edge. Enhancements include new libraries, yeast strains, advanced data management, and in silico tools. Transfer partners also join a global peer network, with summits in Iceland, England, and Vermont. These gatherings feature partner presentations and discussions that accelerate learning and innovation across organizations.
A group of people posing in front of a tour bus on a snowy landscape.

Ready to bring Adimab’s platform in-house?

Empower your team with independent discovery using the industry’s premier biologics platform.

Learn about other ways to partner with us

Funded discovery

Work with Adimab’s team to advance your program without the need to build discovery infrastructure internally.

Non-exclusive programs

Access validated Adimab modules to add plug-and-play functionality to your multispecifics development programs.